APOE and Alzheimer disease: In discriminating MCI+/AD from LBD and controls, the addition of AD‐PRSnoAPOE and APOE‐RS to p‐tau181, age, and sex, resulted in significant improvements in model fit and modest improvements in classification accuracy (AUC).